A three amino acid peptide, Gly-Pro-Arg, protects and rescues cell death induced by amyloid beta-peptide.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Experimental Neurology

• Publication date

  2003-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0014-4886(03)00314-5PMID 14769384
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ

  2004cited by this paper
• Induction of cytochrome c-mediated apoptosis by amyloid beta 25-35 requires functional mitochondria.

  2002cited by this paper
• Reduction of amyloid load and cerebral damage in transgenic mouse model of Alzheimer's disease by treatment with a β‐sheet breaker peptide

  2002cited by this paper
• Caspase‐cleaved Amyloid Precursor Protein in Alzheimer's Disease

  2002cited by this paper
• Activation of caspase-8 in the Alzheimer's disease brain.

  2001cited by this paper
• Multiple caspases are involved in beta-amyloid-induced neuronal apoptosis.

  2001cited by this paper
• A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid β‐peptide

  2001cited by this paper
• A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide.

  2001cited by this paper
• Neuroprotective effects of the N-terminal tripeptide of IGF-1, glycine-proline-glutamate, in the immature rat brain after hypoxic-ischemic injury.

  2001cited by this paper
• Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.

  2001cited by this paper
• Multiple caspases are involved in β‐amyloid‐induced neuronal apoptosis

  2001cited by this paper
• Caspases, Apoptosis, and Alzheimer Disease: Causation, Correlation, and Confusion

  2001cited by this paper
• Caspase-3 activation and DNA fragmentation in primary hippocampal neurons following glutamate excitotoxicity.

  2001cited by this paper
• Caspase-2 Mediates Neuronal Cell Death Induced by β-Amyloid

  2000cited by this paper
• Caspase-2 mediates neuronal cell death induced by beta-amyloid.

  2000cited by this paper
• A second cytotoxic proteolytic peptide derived from amyloid β-protein precursor

  2000cited by this paper
• Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β

  2000cited by this paper
• N-terminal tripeptide of IGF-1 (GPE) prevents the loss of TH positive neurons after 6-OHDA induced nigral lesion in rats.

  2000cited by this paper
• β-Amyloid-induced activation of Caspase-3 in primary cultures of rat neurons

  2000cited by this paper
• Apoptosis and the Nervous System

  2000cited by this paper
• Neurotrophic factors protect cortical synaptic terminals against amyloid and oxidative stress-induced impairment of glucose transport, glutamate transport and mitochondrial function.

  2000cited by this paper
• A novel peptide prevents death in enriched neuronal cultures.

  2000cited by this paper
• A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor.

  2000cited by this paper
• Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8.

  1999cited by this paper
• Changes in caspase expression in Alzheimer's disease: comparison with development and aging.

  1999cited by this paper
• Apoptosis and expression of p53 response proteins and cyclin D1 after cortical impact in rat brain.

  1999cited by this paper
• Bax-Dependent Caspase-3 Activation Is a Key Determinant in p53-Induced Apoptosis in Neurons

  1999cited by this paper
• Mapping the active site in vasoactive intestinal peptide to a core of four amino acids: neuroprotective drug design.

  1999cited by this paper
• Neuronal Apoptosis Induced by β-Amyloid Is Mediated by Caspase-8

  1999cited by this paper
• Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death.

  1999cited by this paper
• Neuroprotective effects of Gly-Pro-Glu, the N-terminal tripeptide of IGF-1, in the hippocampus in vitro.

  1999cited by this paper
• Caspase Dependent DNA Fragmentation Might Be Associated with Excitotoxicity in Alzheimer Disease

  1998cited by this paper
• Hypoxia-induced apoptosis: effect of hypoxic severity and role of p53 in neuronal cell death.

  1998cited by this paper
• Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease.

  1998cited by this paper
• Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease

  1998cited by this paper
• β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy

  1998cited by this paper
• Alzheimer Disease: DMA Fragmentation Indicates Increased Neuronal Vulnerability, but not Apoptosis

  1998cited by this paper
• DNA Damage Distribution in the Human Brain as Shown by In Situ End Labeling; Area‐specific Differences in Aging and Alzheimer Disease in the Absence of Apoptotic Morphology

  1997cited by this paper
• Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity.

  1997cited by this paper
• Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives.

  1997cited by this paper
• Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease.

  1997cited by this paper
• Bax Protein Expression Is Increased in Alzheimer's Brain: Correlations with DNA Damage, Bcl‐2 Expression, and Brain Pathology

  1997cited by this paper
• p53 Expression Induces Apoptosis in Hippocampal Pyramidal Neuron Cultures

  1997cited by this paper
• Changes of p53 in the brains of patients with Alzheimer's disease.

  1997cited by this paper
• A femtomolar-acting neuroprotective peptide.

  1996cited by this paper
• β-Amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells

  1996cited by this paper
• Evidence for p53-Mediated Modulation of Neuronal Viability

  1996cited by this paper
• Up‐regulation of Bcl‐2 is associated with neuronal DNA damage in Alzheimer's disease

  1996cited by this paper
• Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice.

  1996cited by this paper
• Beta-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells.

  1996cited by this paper
• Mechanisms of neuronal degeneration in Alzheimer's disease.

  1996cited by this paper
• p53: puzzle and paradigm.

  1996cited by this paper
• Apoptotic Cell Death Induced by β‐Amyloid1–42 Peptide Is Cell Type Dependent

  1995cited by this paper
• Apoptotic cell death induced by beta-amyloid 1-42 peptide is cell type dependent.

  1995cited by this paper
• In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes

  1995cited by this paper
• Fas antigen expression in brains of patients with Alzheimer-type dementia.

  1995cited by this paper
• The acute neurotoxic effect of beta-amyloid on mature cultures of rat hippocampal neurons is attenuated by the anti-oxidant U-78517F.

  1994cited by this paper
• Staurosporine and K-252 compounds protect hippocampal neurons against amyloid beta-peptide toxicity and oxidative injury.

  1994cited by this paper
• Inhibitors of free radical formation fail to attenuate direct β‐amyloid25–35 peptide‐mediated neurotoxicity in rat hippocampal cultures

  1994cited by this paper
• AMPA/kainate receptor-mediated damage to NADPH-diaphorase-containing neurons is Ca2+ dependent.

  1994cited by this paper
• Toxic effect of a β-amyloid peptide (β22–35) on the hippocampal neuron and its prevention

  1993cited by this paper
• Toxic effect of a beta-amyloid peptide (beta 22-35) on the hippocampal neuron and its prevention.

  1993cited by this paper
• Vitamin E protects nerve cells from amyloid βprotein toxicity

  1992cited by this paper
• Vitamin E protects nerve cells from amyloid beta protein toxicity.

  1992cited by this paper
• Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides.

  1990cited by this paper

• Expression of Neuronal Nicotinic Acetylcholine Receptor and Early Oxidative DNA Damage in Aging Rat Brain—The Effects of Memantine

  2025cites this paper
• Concise Overview of Glypromate Neuropeptide Research: From Chemistry to Pharmacological Applications in Neurosciences

  2023cites this paper
• Organometallic Chemistry of Drugs Based on Iron

  2021cites this paper
• Effects of food-derived bioactive peptides on cognitive deficits and memory decline in neurodegenerative diseases: A review

  2021cites this paper
• Fragile X Syndrome and Targeted Treatments

  2020cites this paper
• Fatty Acid Profile, Phytochemicals, and Other Substances in Canarium odontophyllum Fat Extracted Using Supercritical Carbon Dioxide

  2019cites this paper
• Molecular Docking and Molecular Dynamics Studies of L-Glycyl-L-Glutamic Acid Dipeptide

  2019cites this paper
• Mechanisms of Neuroprotective Effects of Peptides Derived from Natural Materials and Their Production and Assessment.

  2019cites this paper
• Development of glycine-α-methyl-proline-containing tripeptides with neuroprotective properties.

  2016cites this paper
• Sensitive and selective determination of peptides, PG and PGP, using a novel fluorogenic reagent 4-chlorobenzene-1,2-diol

  2015cites this paper
• Ferrocene tripeptide Gly-Pro-Arg conjugates: synthesis and inhibitory effects on Alzheimer's Aβ(1-42) fibrillogenesis and Aβ-induced cytotoxicity in vitro.

  2013cites this paper
• Phytochemicals and Amino Acids: Inducers or Inhibitors of Cell Death?

  2012cites this paper
• Selective and sensitive determination of peptides using 3,4-dihydroxyphenylacetic acid as a fluorogenic reagent.

  2012cites this paper
• Natural compounds as inducers of cell death

  2012cites this paper
• Randomization of amyloid-β-peptide(1-42) conformation by sulfonated and sulfated nanoparticles reduces aggregation and cytotoxicity.

  2010cites this paper
• Influence of aluminum toxicosis on the activity of adenosine deaminase and dipeptidyl peptidases II and IV

  2009cites this paper
• Interaction studies between biocompatible polymers and amyloid-B peptides

  2009cites this paper
• Aβ Mediated Diminution of MTT Reduction—An Artefact of Single Cell Culture?

  2008cites this paper
• Amyloid-beta peptide affects viability but not differentiation of embryonic and adult rat hippocampal progenitor cells

  2007cites this paper
• Tuning of the prolyl trans/cis-amide rotamer population by use of C-glucosylproline hybrids.

  2007cites this paper
• Glyprolines in regulatory tripeptides

  2007cites this paper
• In vitro evaluation of N-methyl amide tripeptidomimetics as substrates for the human intestinal di-/tri-peptide transporter hPEPT1.

  2006cites this paper
• Neuroprotective peptides as drug candidates against Alzheimer's diasease

  2005cites this paper
• Differential neuronal expression of manganese superoxide dismutase in Alzheimer's disease.

  2005cites this paper
• Polymorphisms of the CHRNA4 Gene Encoding the α4 Subunit of Nicotinic Acetylcholine Receptor as Related to the Oxidative DNA Damage and the Level of Apoptotic Proteins in Lymphocytes of the Patients with Alzheimer's Disease

  2005cites this paper
• Gly-Pro-Glu protects &bgr;-amyloid-induced somatostatin depletion in the rat cortex

  2004cites this paper